

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.29948668 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.29948668 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.00890743 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.00890743 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.78760690 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.60544167 |
| 7 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.12152997 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.99534706 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.99534706 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.99534706 |
| 11 | high-density lipoprotein particle remodeling (GO:0034375) | 5.90238115 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.90008535 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.88231738 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.85263362 |
| 15 | epoxygenase P450 pathway (GO:0019373) | 5.82238786 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.64227244 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.57769620 |
| 18 | urea metabolic process (GO:0019627) | 5.55004856 |
| 19 | urea cycle (GO:0000050) | 5.55004856 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.50961577 |
| 21 | regulation of cholesterol esterification (GO:0010872) | 5.48120723 |
| 22 | * intestinal absorption (GO:0050892) | 5.47493399 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.27992693 |
| 24 | protein carboxylation (GO:0018214) | 5.25170171 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.25170171 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 5.13767736 |
| 27 | phospholipid efflux (GO:0033700) | 5.13526964 |
| 28 | cysteine metabolic process (GO:0006534) | 5.11757472 |
| 29 | reverse cholesterol transport (GO:0043691) | 5.11724127 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.10429277 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.09878498 |
| 32 | plasma lipoprotein particle remodeling (GO:0034369) | 5.07183387 |
| 33 | protein-lipid complex remodeling (GO:0034368) | 5.07183387 |
| 34 | macromolecular complex remodeling (GO:0034367) | 5.07183387 |
| 35 | bile acid metabolic process (GO:0008206) | 5.05370142 |
| 36 | regulation of protein activation cascade (GO:2000257) | 5.05028424 |
| 37 | complement activation, alternative pathway (GO:0006957) | 5.03001583 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.00868888 |
| 39 | angiotensin maturation (GO:0002003) | 4.99997943 |
| 40 | negative regulation of cholesterol transport (GO:0032375) | 4.94564681 |
| 41 | negative regulation of sterol transport (GO:0032372) | 4.94564681 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 4.90930749 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.80687685 |
| 44 | regulation of complement activation (GO:0030449) | 4.68918671 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.66833663 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.66833663 |
| 47 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.66514417 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.60508977 |
| 49 | plasma lipoprotein particle clearance (GO:0034381) | 4.59147935 |
| 50 | cholesterol efflux (GO:0033344) | 4.56518082 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 4.56289900 |
| 52 | diacylglycerol metabolic process (GO:0046339) | 4.52409507 |
| 53 | homocysteine metabolic process (GO:0050667) | 4.50316148 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.47227190 |
| 55 | lysine metabolic process (GO:0006553) | 4.46913985 |
| 56 | lysine catabolic process (GO:0006554) | 4.46913985 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 4.45307833 |
| 58 | exogenous drug catabolic process (GO:0042738) | 4.44032591 |
| 59 | plasma lipoprotein particle assembly (GO:0034377) | 4.41552986 |
| 60 | bile acid and bile salt transport (GO:0015721) | 4.41417403 |
| 61 | ethanol metabolic process (GO:0006067) | 4.37216017 |
| 62 | cellular glucuronidation (GO:0052695) | 4.28622549 |
| 63 | indolalkylamine metabolic process (GO:0006586) | 4.24556680 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.24178536 |
| 65 | drug metabolic process (GO:0017144) | 4.23436480 |
| 66 | glycine metabolic process (GO:0006544) | 4.22297920 |
| 67 | drug catabolic process (GO:0042737) | 4.19699648 |
| 68 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 4.17825597 |
| 69 | low-density lipoprotein particle remodeling (GO:0034374) | 4.16869589 |
| 70 | amine catabolic process (GO:0009310) | 4.16028763 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 4.16028763 |
| 72 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.15735578 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 4.13512764 |
| 74 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.13187386 |
| 75 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.13187386 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 4.11518682 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 4.11113782 |
| 78 | glutamate metabolic process (GO:0006536) | 4.08622940 |
| 79 | ethanol oxidation (GO:0006069) | 4.05179842 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 4.00794742 |
| 81 | lipoprotein transport (GO:0042953) | 3.97685872 |
| 82 | protein-lipid complex assembly (GO:0065005) | 3.96580091 |
| 83 | NADH metabolic process (GO:0006734) | 3.94918398 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.93879855 |
| 85 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.93534925 |
| 86 | endocrine process (GO:0050886) | 3.93534925 |
| 87 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.93534925 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.91688924 |
| 89 | arginine metabolic process (GO:0006525) | 3.91478760 |
| 90 | cellular modified amino acid catabolic process (GO:0042219) | 3.89792118 |
| 91 | fibrinolysis (GO:0042730) | 3.88778324 |
| 92 | plasma lipoprotein particle organization (GO:0071827) | 3.87654690 |
| 93 | cholesterol homeostasis (GO:0042632) | 3.87592593 |
| 94 | ketone body metabolic process (GO:1902224) | 3.85307954 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 3.85229855 |
| 96 | regulation of guanylate cyclase activity (GO:0031282) | 3.83223187 |
| 97 | phospholipid homeostasis (GO:0055091) | 3.82084348 |
| 98 | aldehyde catabolic process (GO:0046185) | 3.82074882 |
| 99 | sterol homeostasis (GO:0055092) | 3.81177025 |
| 100 | uronic acid metabolic process (GO:0006063) | 3.80232910 |
| 101 | glucuronate metabolic process (GO:0019585) | 3.80232910 |
| 102 | intestinal cholesterol absorption (GO:0030299) | 3.78910752 |
| 103 | blood coagulation, intrinsic pathway (GO:0007597) | 3.73499733 |
| 104 | cofactor catabolic process (GO:0051187) | 3.72137208 |
| 105 | sulfate transmembrane transport (GO:1902358) | 3.71970096 |
| 106 | flavonoid metabolic process (GO:0009812) | 3.71266427 |
| 107 | protein activation cascade (GO:0072376) | 3.71146165 |
| 108 | renal system process involved in regulation of blood volume (GO:0001977) | 3.71108139 |
| 109 | short-chain fatty acid metabolic process (GO:0046459) | 3.71091036 |
| 110 | regulation of bile acid biosynthetic process (GO:0070857) | 3.70521782 |
| 111 | negative regulation of hemostasis (GO:1900047) | 3.69792661 |
| 112 | negative regulation of blood coagulation (GO:0030195) | 3.69792661 |
| 113 | drug transmembrane transport (GO:0006855) | 3.68350921 |
| 114 | * positive regulation of lipid catabolic process (GO:0050996) | 3.67985595 |
| 115 | lipoprotein metabolic process (GO:0042157) | 3.67247494 |
| 116 | organic acid catabolic process (GO:0016054) | 3.66413676 |
| 117 | carboxylic acid catabolic process (GO:0046395) | 3.66413676 |
| 118 | heme transport (GO:0015886) | 3.66113875 |
| 119 | protein-lipid complex subunit organization (GO:0071825) | 3.65018706 |
| 120 | regulation of cholesterol homeostasis (GO:2000188) | 3.64068940 |
| 121 | acetyl-CoA metabolic process (GO:0006084) | 3.62547584 |
| 122 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.60213247 |
| 123 | complement activation, classical pathway (GO:0006958) | 3.59227392 |
| 124 | regulation of plasminogen activation (GO:0010755) | 3.54888116 |
| 125 | regulation of apoptotic cell clearance (GO:2000425) | 3.54399691 |
| 126 | hormone catabolic process (GO:0042447) | 3.45940435 |
| 127 | complement activation (GO:0006956) | 3.45903857 |
| 128 | proline metabolic process (GO:0006560) | 3.44412033 |
| 129 | acute-phase response (GO:0006953) | 3.44024082 |
| 130 | drug transport (GO:0015893) | 3.43977177 |
| 131 | negative regulation of coagulation (GO:0050819) | 3.43150683 |
| 132 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.33225703 |
| 133 | fructose metabolic process (GO:0006000) | 3.30927729 |
| 134 | regulation of systemic arterial blood pressure (GO:0003073) | 3.30382861 |
| 135 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.27132481 |
| 136 | phenylpropanoid metabolic process (GO:0009698) | 3.20646820 |
| 137 | negative regulation of wound healing (GO:0061045) | 3.20574803 |
| 138 | regulation of cholesterol metabolic process (GO:0090181) | 3.18180908 |
| 139 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.13310705 |
| 140 | negative regulation of protein activation cascade (GO:2000258) | 3.11282159 |
| 141 | transcytosis (GO:0045056) | 3.11195142 |
| 142 | vitamin transmembrane transport (GO:0035461) | 3.07205140 |
| 143 | omega-hydroxylase P450 pathway (GO:0097267) | 3.06484987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.33837183 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19358921 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.99562433 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.49879292 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.08549208 |
| 6 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.07337327 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.98967915 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04101271 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.96476300 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.21878782 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30858893 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.10571032 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04737013 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00208503 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8425158 |
| 16 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.80126326 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.74034411 |
| 18 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.70846690 |
| 19 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60868109 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58460677 |
| 21 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55304054 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.50805100 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47341057 |
| 24 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43078168 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42743968 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26871711 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24309638 |
| 28 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20641752 |
| 29 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.18175870 |
| 30 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17107478 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11203844 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10170079 |
| 33 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09911613 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07189617 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05614533 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04454022 |
| 37 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03599727 |
| 38 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03461378 |
| 39 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02707331 |
| 40 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02230659 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99902150 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98941323 |
| 43 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97021802 |
| 44 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.96640428 |
| 45 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94771437 |
| 46 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.93769227 |
| 47 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93594357 |
| 48 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91727411 |
| 49 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91602152 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91388673 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88151862 |
| 52 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.87017775 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85322785 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83135945 |
| 55 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82481971 |
| 56 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81788985 |
| 57 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.81352964 |
| 58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.81168611 |
| 59 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.80009067 |
| 60 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79729715 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79512842 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78822265 |
| 63 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76807992 |
| 64 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.76709384 |
| 65 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75670596 |
| 66 | SA1_27219007_Chip-Seq_Bcells_Human | 0.75477158 |
| 67 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.75093085 |
| 68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73887535 |
| 69 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73876527 |
| 70 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73790348 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.73484105 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70509363 |
| 73 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.70150356 |
| 74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70054927 |
| 75 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.69997298 |
| 76 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.69170614 |
| 77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69164688 |
| 78 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.68873884 |
| 79 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68836286 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68712290 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67900081 |
| 82 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.66476292 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65770300 |
| 84 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.65632412 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65105015 |
| 86 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65006750 |
| 87 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.64775894 |
| 88 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.64211543 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64075644 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64075644 |
| 91 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62471977 |
| 92 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62422604 |
| 93 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62073587 |
| 94 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59505919 |
| 95 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55859268 |
| 96 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54699490 |
| 97 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53384463 |
| 98 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.52981755 |
| 99 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52962068 |
| 100 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52674234 |
| 101 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52208945 |
| 102 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52076323 |
| 103 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50652684 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.50010263 |
| 105 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49996380 |
| 106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49970002 |
| 107 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49367799 |
| 108 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48762903 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.47634866 |
| 110 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.47624664 |
| 111 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47038031 |
| 112 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46710116 |
| 113 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45171615 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.44418222 |
| 115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43931163 |
| 116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43753767 |
| 117 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43727501 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.43605967 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.42995707 |
| 120 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41983493 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41688015 |
| 122 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40659607 |
| 123 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40478516 |
| 124 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.40444750 |
| 125 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40437166 |
| 126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39117783 |
| 127 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36380674 |
| 128 | NCOR_22424771_ChIP-Seq_293T_Human | 0.36081007 |
| 129 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.35886195 |
| 130 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35626408 |
| 131 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.35185505 |
| 132 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35166311 |
| 133 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35080524 |
| 134 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35077228 |
| 135 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34803468 |
| 136 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.34225204 |
| 137 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.33859967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0002139_abnormal_hepatobiliary_system | 7.73822615 |
| 2 | MP0005360_urolithiasis | 7.72961015 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.51966942 |
| 4 | MP0005365_abnormal_bile_salt | 6.35174201 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.21732276 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.19889720 |
| 7 | MP0003252_abnormal_bile_duct | 4.03665887 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.70885733 |
| 9 | MP0009840_abnormal_foam_cell | 3.61626655 |
| 10 | MP0005083_abnormal_biliary_tract | 3.06704649 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.85909660 |
| 12 | MP0005332_abnormal_amino_acid | 2.71929524 |
| 13 | MP0003195_calcinosis | 2.68197437 |
| 14 | MP0003183_abnormal_peptide_metabolism | 2.47559403 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.32473543 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.17063814 |
| 17 | * MP0000609_abnormal_liver_physiology | 2.15587258 |
| 18 | * MP0002118_abnormal_lipid_homeostasis | 2.12216426 |
| 19 | MP0003866_abnormal_defecation | 2.01656514 |
| 20 | MP0004043_abnormal_pH_regulation | 1.95262215 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.94830518 |
| 22 | MP0003868_abnormal_feces_composition | 1.88434260 |
| 23 | MP0005409_darkened_coat_color | 1.87948654 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.81847006 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.80141787 |
| 26 | MP0009697_abnormal_copulation | 1.72587496 |
| 27 | MP0001764_abnormal_homeostasis | 1.67436485 |
| 28 | MP0000566_synostosis | 1.57254420 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54485607 |
| 30 | MP0004147_increased_porphyrin_level | 1.54130086 |
| 31 | MP0005451_abnormal_body_composition | 1.54070280 |
| 32 | MP0009379_abnormal_foot_pigmentation | 1.53066397 |
| 33 | MP0000477_abnormal_intestine_morphology | 1.44092775 |
| 34 | MP0001765_abnormal_ion_homeostasis | 1.39523192 |
| 35 | MP0001664_abnormal_digestion | 1.39338824 |
| 36 | MP0003122_maternal_imprinting | 1.37458783 |
| 37 | MP0010352_gastrointestinal_tract_polyps | 1.37074078 |
| 38 | MP0003011_delayed_dark_adaptation | 1.35119416 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.30692883 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.24069493 |
| 41 | MP0001663_abnormal_digestive_system | 1.21388957 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.20418053 |
| 43 | MP0003879_abnormal_hair_cell | 1.20197388 |
| 44 | MP0003186_abnormal_redox_activity | 1.19338471 |
| 45 | MP0000598_abnormal_liver_morphology | 1.15508491 |
| 46 | MP0005647_abnormal_sex_gland | 1.11189008 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 1.11050628 |
| 48 | MP0000604_amyloidosis | 1.10833363 |
| 49 | MP0002089_abnormal_postnatal_growth/wei | 1.07450292 |
| 50 | MP0000678_abnormal_parathyroid_gland | 1.07009480 |
| 51 | MP0009764_decreased_sensitivity_to | 1.06012438 |
| 52 | MP0000490_abnormal_crypts_of | 1.05764139 |
| 53 | MP0002254_reproductive_system_inflammat | 1.01473860 |
| 54 | MP0009763_increased_sensitivity_to | 0.99618937 |
| 55 | MP0005381_digestive/alimentary_phenotyp | 0.99348050 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 0.94279207 |
| 57 | MP0010368_abnormal_lymphatic_system | 0.89666933 |
| 58 | MP0005084_abnormal_gallbladder_morpholo | 0.89176745 |
| 59 | MP0008469_abnormal_protein_level | 0.88850588 |
| 60 | * MP0009642_abnormal_blood_homeostasis | 0.87310287 |
| 61 | MP0001873_stomach_inflammation | 0.84526276 |
| 62 | MP0005408_hypopigmentation | 0.81533080 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 0.81120604 |
| 64 | MP0005376_homeostasis/metabolism_phenot | 0.80532053 |
| 65 | MP0002876_abnormal_thyroid_physiology | 0.79279338 |
| 66 | MP0009765_abnormal_xenobiotic_induced | 0.78623297 |
| 67 | * MP0002078_abnormal_glucose_homeostasis | 0.75651508 |
| 68 | MP0003172_abnormal_lysosome_physiology | 0.74970473 |
| 69 | MP0005257_abnormal_intraocular_pressure | 0.73916875 |
| 70 | MP0003123_paternal_imprinting | 0.73272827 |
| 71 | MP0002166_altered_tumor_susceptibility | 0.72354894 |
| 72 | MP0002971_abnormal_brown_adipose | 0.71899166 |
| 73 | MP0005334_abnormal_fat_pad | 0.71326293 |
| 74 | MP0009053_abnormal_anal_canal | 0.70268063 |
| 75 | MP0004858_abnormal_nervous_system | 0.69991269 |
| 76 | MP0002098_abnormal_vibrissa_morphology | 0.68484022 |
| 77 | MP0005670_abnormal_white_adipose | 0.68361015 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 0.67003412 |
| 79 | MP0003690_abnormal_glial_cell | 0.66814292 |
| 80 | MP0005266_abnormal_metabolism | 0.66309563 |
| 81 | MP0003329_amyloid_beta_deposits | 0.65179459 |
| 82 | MP0005535_abnormal_body_temperature | 0.65013912 |
| 83 | MP0004130_abnormal_muscle_cell | 0.64848153 |
| 84 | MP0005448_abnormal_energy_balance | 0.62488228 |
| 85 | MP0003315_abnormal_perineum_morphology | 0.60374612 |
| 86 | MP0009785_altered_susceptibility_to | 0.60370102 |
| 87 | MP0002822_catalepsy | 0.59378398 |
| 88 | MP0000639_abnormal_adrenal_gland | 0.59319440 |
| 89 | MP0001661_extended_life_span | 0.58694993 |
| 90 | MP0001756_abnormal_urination | 0.58555572 |
| 91 | MP0009780_abnormal_chondrocyte_physiolo | 0.58546652 |
| 92 | MP0003567_abnormal_fetal_cardiomyocyte | 0.58173768 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.57549909 |
| 94 | MP0000462_abnormal_digestive_system | 0.57262727 |
| 95 | MP0005464_abnormal_platelet_physiology | 0.53813527 |
| 96 | MP0002896_abnormal_bone_mineralization | 0.52693275 |
| 97 | MP0009333_abnormal_splenocyte_physiolog | 0.52209330 |
| 98 | MP0000538_abnormal_urinary_bladder | 0.50095838 |
| 99 | MP0003718_maternal_effect | 0.48537532 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.47549601 |
| 101 | MP0005395_other_phenotype | 0.46899370 |
| 102 | MP0005023_abnormal_wound_healing | 0.46589824 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.46583527 |
| 104 | MP0003303_peritoneal_inflammation | 0.46396241 |
| 105 | MP0003300_gastrointestinal_ulcer | 0.46312948 |
| 106 | MP0008874_decreased_physiological_sensi | 0.45609595 |
| 107 | MP0008873_increased_physiological_sensi | 0.44912874 |
| 108 | MP0002928_abnormal_bile_duct | 0.43594918 |
| 109 | MP0005025_abnormal_response_to | 0.42456117 |
| 110 | MP0001915_intracranial_hemorrhage | 0.42068470 |
| 111 | MP0006054_spinal_hemorrhage | 0.41414715 |
| 112 | MP0008872_abnormal_physiological_respon | 0.40348169 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.40321841 |
| 114 | MP0003075_altered_response_to | 0.39508685 |
| 115 | * MP0003953_abnormal_hormone_level | 0.39429634 |
| 116 | MP0005248_abnormal_Harderian_gland | 0.39177742 |
| 117 | MP0003724_increased_susceptibility_to | 0.38937291 |
| 118 | MP0005166_decreased_susceptibility_to | 0.38260380 |
| 119 | MP0002796_impaired_skin_barrier | 0.37908611 |
| 120 | MP0003436_decreased_susceptibility_to | 0.37640336 |
| 121 | MP0002837_dystrophic_cardiac_calcinosis | 0.35799323 |
| 122 | MP0009115_abnormal_fat_cell | 0.35562038 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.35418303 |
| 124 | MP0000579_abnormal_nail_morphology | 0.33674863 |
| 125 | MP0004381_abnormal_hair_follicle | 0.33596632 |
| 126 | MP0000249_abnormal_blood_vessel | 0.33003006 |
| 127 | MP0006082_CNS_inflammation | 0.32998866 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.32383445 |
| 129 | MP0001881_abnormal_mammary_gland | 0.32371426 |
| 130 | MP0009672_abnormal_birth_weight | 0.32279485 |
| 131 | MP0001243_abnormal_dermal_layer | 0.31551691 |
| 132 | MP0004883_abnormal_blood_vessel | 0.31426429 |
| 133 | MP0002970_abnormal_white_adipose | 0.29260239 |
| 134 | MP0004264_abnormal_extraembryonic_tissu | 0.29176899 |
| 135 | MP0001853_heart_inflammation | 0.29128967 |
| 136 | MP0001845_abnormal_inflammatory_respons | 0.28034796 |
| 137 | MP0002168_other_aberrant_phenotype | 0.27730108 |
| 138 | MP0009384_cardiac_valve_regurgitation | 0.27360458 |
| 139 | MP0010234_abnormal_vibrissa_follicle | 0.26604410 |
| 140 | MP0005164_abnormal_response_to | 0.23994170 |
| 141 | MP0002132_abnormal_respiratory_system | 0.23948409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.31228721 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.29178792 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.19077230 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.83180140 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.63911925 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.49049717 |
| 7 | Xanthomatosis (HP:0000991) | 6.35148516 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.50810487 |
| 9 | Complement deficiency (HP:0004431) | 5.04063045 |
| 10 | Hypolipoproteinemia (HP:0010981) | 5.00595741 |
| 11 | Joint hemorrhage (HP:0005261) | 4.70681533 |
| 12 | Hyperammonemia (HP:0001987) | 4.58196036 |
| 13 | Epidermoid cyst (HP:0200040) | 4.55837125 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.54430662 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.37624118 |
| 16 | Hyperactive renin-angiotensin system (HP:0000841) | 4.33590496 |
| 17 | Hyperglycinemia (HP:0002154) | 4.31169704 |
| 18 | Flat acetabular roof (HP:0003180) | 4.27205758 |
| 19 | Fat malabsorption (HP:0002630) | 4.26651259 |
| 20 | Ketosis (HP:0001946) | 4.22642456 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.22248954 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.16563082 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.14689024 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 4.10981071 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.06008370 |
| 26 | Hypoglycemic coma (HP:0001325) | 4.01622361 |
| 27 | Hyperglycinuria (HP:0003108) | 3.91870158 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.88738270 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.87567808 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.87567808 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.79000272 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.77432994 |
| 33 | Metabolic alkalosis (HP:0200114) | 3.75144468 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.70582860 |
| 35 | Abnormality of complement system (HP:0005339) | 3.67329516 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.42911274 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.41776129 |
| 38 | Abnormal tarsal ossification (HP:0008369) | 3.41630744 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.37671026 |
| 40 | Alkalosis (HP:0001948) | 3.21287704 |
| 41 | Decreased circulating renin level (HP:0003351) | 3.17109781 |
| 42 | Ileus (HP:0002595) | 3.11916726 |
| 43 | Abnormality of renin-angiotensin system (HP:0000847) | 3.11658004 |
| 44 | Steatorrhea (HP:0002570) | 3.11327149 |
| 45 | Abnormality of carpal bone ossification (HP:0006257) | 3.10730538 |
| 46 | Ketoacidosis (HP:0001993) | 3.08990357 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06681912 |
| 48 | Delayed CNS myelination (HP:0002188) | 3.03670639 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 2.95748847 |
| 50 | Widely patent fontanelles and sutures (HP:0004492) | 2.93328111 |
| 51 | Spontaneous abortion (HP:0005268) | 2.93097312 |
| 52 | Nephritis (HP:0000123) | 2.91854696 |
| 53 | Acanthocytosis (HP:0001927) | 2.89442410 |
| 54 | Hypochromic microcytic anemia (HP:0004840) | 2.88063639 |
| 55 | Hepatocellular carcinoma (HP:0001402) | 2.86961995 |
| 56 | Myocardial infarction (HP:0001658) | 2.84744383 |
| 57 | Metabolic acidosis (HP:0001942) | 2.81614278 |
| 58 | Skin nodule (HP:0200036) | 2.78777500 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 2.70522731 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.63863096 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.58677706 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.58677706 |
| 63 | Vascular calcification (HP:0004934) | 2.58657006 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.58424167 |
| 65 | Lethargy (HP:0001254) | 2.58393422 |
| 66 | Abdominal distention (HP:0003270) | 2.57475239 |
| 67 | Abnormal gallbladder morphology (HP:0012437) | 2.50325469 |
| 68 | Malnutrition (HP:0004395) | 2.48967207 |
| 69 | Right ventricular cardiomyopathy (HP:0011663) | 2.47848454 |
| 70 | Cholecystitis (HP:0001082) | 2.45040143 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.45040143 |
| 72 | Cholelithiasis (HP:0001081) | 2.43961347 |
| 73 | Spastic diplegia (HP:0001264) | 2.43435277 |
| 74 | Abnormality of chloride homeostasis (HP:0011422) | 2.41979892 |
| 75 | Cerebral edema (HP:0002181) | 2.36738768 |
| 76 | Glomerulonephritis (HP:0000099) | 2.36209661 |
| 77 | Amyloidosis (HP:0011034) | 2.35754241 |
| 78 | Mitral stenosis (HP:0001718) | 2.34291921 |
| 79 | Irritability (HP:0000737) | 2.33745795 |
| 80 | Abnormal hand bone ossification (HP:0010660) | 2.33523434 |
| 81 | Pigmentary retinal degeneration (HP:0001146) | 2.33348518 |
| 82 | Abnormal ossification of hand bones (HP:0005921) | 2.30610737 |
| 83 | Proximal tubulopathy (HP:0000114) | 2.30241175 |
| 84 | Cardiovascular calcification (HP:0011915) | 2.29118738 |
| 85 | Neonatal short-limb short stature (HP:0008921) | 2.28761928 |
| 86 | Late onset (HP:0003584) | 2.27446749 |
| 87 | Purpura (HP:0000979) | 2.26233027 |
| 88 | Neonatal onset (HP:0003623) | 2.25470521 |
| 89 | Gout (HP:0001997) | 2.24980360 |
| 90 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.23131273 |
| 91 | Potter facies (HP:0002009) | 2.21883525 |
| 92 | Facial shape deformation (HP:0011334) | 2.21883525 |
| 93 | Poikilocytosis (HP:0004447) | 2.21214206 |
| 94 | Gingival bleeding (HP:0000225) | 2.18651903 |
| 95 | Wide cranial sutures (HP:0010537) | 2.18276891 |
| 96 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18200829 |
| 97 | Brushfield spots (HP:0001088) | 2.17332686 |
| 98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.16279865 |
| 99 | Sensorimotor neuropathy (HP:0007141) | 2.15898733 |
| 100 | Hypotension (HP:0002615) | 2.15682018 |
| 101 | Esophageal varix (HP:0002040) | 2.15524661 |
| 102 | Pancreatitis (HP:0001733) | 2.14742859 |
| 103 | Abnormal foot bone ossification (HP:0010675) | 2.14696748 |
| 104 | Menorrhagia (HP:0000132) | 2.11674976 |
| 105 | Chronic diarrhea (HP:0002028) | 2.07289542 |
| 106 | Hyperaldosteronism (HP:0000859) | 2.07149569 |
| 107 | Abnormality of vitamin B metabolism (HP:0004340) | 2.06541455 |
| 108 | Vomiting (HP:0002013) | 2.05994596 |
| 109 | Generalized aminoaciduria (HP:0002909) | 2.03625433 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 2.02709577 |
| 111 | Abnormality of the gallbladder (HP:0005264) | 2.02051475 |
| 112 | Opisthotonus (HP:0002179) | 2.02017691 |
| 113 | Thrombophlebitis (HP:0004418) | 2.00541851 |
| 114 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00356172 |
| 115 | Enlarged kidneys (HP:0000105) | 2.00120416 |
| 116 | Rickets (HP:0002748) | 1.98607574 |
| 117 | Focal segmental glomerulosclerosis (HP:0000097) | 1.98225748 |
| 118 | Hypophosphatemia (HP:0002148) | 1.96527697 |
| 119 | Hemorrhage of the eye (HP:0011885) | 1.96254961 |
| 120 | Thin bony cortex (HP:0002753) | 1.95391129 |
| 121 | Abnormality of proline metabolism (HP:0010907) | 1.93419649 |
| 122 | Hydroxyprolinuria (HP:0003080) | 1.93419649 |
| 123 | Hyponatremia (HP:0002902) | 1.93074007 |
| 124 | Confusion (HP:0001289) | 1.92434466 |
| 125 | Renal cortical cysts (HP:0000803) | 1.89787926 |
| 126 | Abnormal cartilage morphology (HP:0002763) | 1.88799673 |
| 127 | Increased serum pyruvate (HP:0003542) | 1.84565688 |
| 128 | Reticulocytosis (HP:0001923) | 1.83295171 |
| 129 | Hypokalemia (HP:0002900) | 1.82487969 |
| 130 | Glomerulosclerosis (HP:0000096) | 1.82375735 |
| 131 | Hyperphosphaturia (HP:0003109) | 1.82226506 |
| 132 | Abnormality of vitamin metabolism (HP:0100508) | 1.81622954 |
| 133 | Abnormality of urine glucose concentration (HP:0011016) | 1.81255946 |
| 134 | Glycosuria (HP:0003076) | 1.81255946 |
| 135 | Hyperglycemia (HP:0003074) | 1.80979854 |
| 136 | Cupped ribs (HP:0000887) | 1.80328338 |
| 137 | Hypophosphatemic rickets (HP:0004912) | 1.79898289 |
| 138 | Nephrolithiasis (HP:0000787) | 1.79337016 |
| 139 | Elevated hepatic transaminases (HP:0002910) | 1.79302318 |
| 140 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78001541 |
| 141 | Osteomalacia (HP:0002749) | 1.77684802 |
| 142 | Visceral angiomatosis (HP:0100761) | 1.76235637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.98721996 |
| 2 | ACVR1B | 4.85335017 |
| 3 | SIK1 | 4.58310030 |
| 4 | FGFR4 | 4.36480535 |
| 5 | ERN1 | 4.28001373 |
| 6 | EPHA2 | 4.16006798 |
| 7 | TAOK3 | 3.27959596 |
| 8 | INSRR | 2.91749443 |
| 9 | ERBB4 | 2.74394258 |
| 10 | LMTK2 | 2.53177475 |
| 11 | MST1R | 2.39775901 |
| 12 | PKN2 | 2.33984959 |
| 13 | WNK4 | 2.32686391 |
| 14 | MAP2K4 | 2.25681661 |
| 15 | PIK3CG | 2.04334206 |
| 16 | FLT3 | 1.96222135 |
| 17 | FRK | 1.88761240 |
| 18 | MAPK11 | 1.84117234 |
| 19 | DAPK2 | 1.83723699 |
| 20 | STK39 | 1.82777352 |
| 21 | TRIB3 | 1.68650988 |
| 22 | TYK2 | 1.66716020 |
| 23 | LATS1 | 1.62226996 |
| 24 | PTK6 | 1.58016268 |
| 25 | DDR2 | 1.52088139 |
| 26 | ABL2 | 1.44169808 |
| 27 | MAP3K2 | 1.42658207 |
| 28 | GRK6 | 1.32085615 |
| 29 | FGFR2 | 1.30462082 |
| 30 | NEK9 | 1.30279742 |
| 31 | KDR | 1.30276424 |
| 32 | PDGFRA | 1.26817135 |
| 33 | MAP3K7 | 1.21975674 |
| 34 | JAK2 | 1.19025316 |
| 35 | PRKAA2 | 1.18926651 |
| 36 | MAP3K10 | 1.17091111 |
| 37 | EPHB2 | 1.14797605 |
| 38 | TBK1 | 1.11810194 |
| 39 | TESK2 | 1.07936876 |
| 40 | STK24 | 1.06142927 |
| 41 | PINK1 | 1.02621220 |
| 42 | MAP3K12 | 1.01299545 |
| 43 | MAP2K3 | 1.00393152 |
| 44 | MAP3K14 | 0.99326641 |
| 45 | ERBB2 | 0.98851119 |
| 46 | TYRO3 | 0.98778697 |
| 47 | CDK12 | 0.98494078 |
| 48 | MATK | 0.98466573 |
| 49 | MAPK4 | 0.97451117 |
| 50 | JAK1 | 0.95791133 |
| 51 | PDK2 | 0.95018175 |
| 52 | MET | 0.93431248 |
| 53 | CDC42BPA | 0.91805312 |
| 54 | PRKCZ | 0.91315282 |
| 55 | MAP3K11 | 0.90464211 |
| 56 | MAP3K3 | 0.86658715 |
| 57 | EPHB1 | 0.84006268 |
| 58 | MAPK15 | 0.83112677 |
| 59 | FGFR1 | 0.82247743 |
| 60 | CAMK1D | 0.80235452 |
| 61 | RIPK1 | 0.79860394 |
| 62 | CDK6 | 0.79860171 |
| 63 | PRKACG | 0.79209767 |
| 64 | STK38L | 0.77323731 |
| 65 | MAP2K6 | 0.76065915 |
| 66 | CSK | 0.75734862 |
| 67 | MAPK12 | 0.75381959 |
| 68 | DYRK1B | 0.75128496 |
| 69 | CAMK2G | 0.72768608 |
| 70 | TIE1 | 0.70018619 |
| 71 | EEF2K | 0.67867257 |
| 72 | MAPKAPK3 | 0.67427779 |
| 73 | WNK1 | 0.67388639 |
| 74 | PRKAA1 | 0.66415361 |
| 75 | EPHA3 | 0.66090235 |
| 76 | GSK3A | 0.64653832 |
| 77 | KSR2 | 0.62040749 |
| 78 | SMG1 | 0.61954148 |
| 79 | IRAK3 | 0.61461728 |
| 80 | PTK2 | 0.57964172 |
| 81 | PRPF4B | 0.57134340 |
| 82 | SGK3 | 0.56662415 |
| 83 | PDPK1 | 0.55700043 |
| 84 | MYLK | 0.55298206 |
| 85 | IKBKE | 0.54154408 |
| 86 | SRC | 0.53829872 |
| 87 | OXSR1 | 0.53590365 |
| 88 | PRKCQ | 0.52976281 |
| 89 | NLK | 0.52804606 |
| 90 | CSF1R | 0.52716974 |
| 91 | EPHA4 | 0.52094921 |
| 92 | MAPK7 | 0.50616977 |
| 93 | FGFR3 | 0.49762250 |
| 94 | TGFBR2 | 0.48828766 |
| 95 | MAP2K1 | 0.48538493 |
| 96 | TAOK1 | 0.48163808 |
| 97 | PIK3CA | 0.46527894 |
| 98 | TAOK2 | 0.46465201 |
| 99 | FGR | 0.46286396 |
| 100 | CSNK1G1 | 0.46111287 |
| 101 | GRK1 | 0.46059704 |
| 102 | FER | 0.45490578 |
| 103 | IGF1R | 0.44970286 |
| 104 | ICK | 0.42660743 |
| 105 | CAMK2D | 0.42403492 |
| 106 | RET | 0.41352527 |
| 107 | MAP3K5 | 0.40672370 |
| 108 | PBK | 0.40627071 |
| 109 | CDK4 | 0.39279082 |
| 110 | MAP3K13 | 0.39080124 |
| 111 | RIPK4 | 0.38894250 |
| 112 | PDK1 | 0.37074698 |
| 113 | TESK1 | 0.36819294 |
| 114 | YES1 | 0.36370908 |
| 115 | PRKCG | 0.35597999 |
| 116 | SGK2 | 0.35497070 |
| 117 | SGK1 | 0.33784513 |
| 118 | MTOR | 0.33186472 |
| 119 | MAPKAPK2 | 0.32891511 |
| 120 | MAP2K2 | 0.32811986 |
| 121 | CAMK4 | 0.32156459 |
| 122 | RPS6KB1 | 0.31933913 |
| 123 | EGFR | 0.31932344 |
| 124 | PAK4 | 0.31541305 |
| 125 | MAP4K1 | 0.31198546 |
| 126 | MAP3K1 | 0.30963308 |
| 127 | AKT3 | 0.29706527 |
| 128 | MAP3K6 | 0.29506162 |
| 129 | PRKCA | 0.29256336 |
| 130 | BCR | 0.28595910 |
| 131 | ZAP70 | 0.27827810 |
| 132 | FYN | 0.27762597 |
| 133 | CSNK1G2 | 0.27366772 |
| 134 | PKN1 | 0.26652289 |
| 135 | BMX | 0.26083960 |
| 136 | CAMK1G | 0.25900409 |
| 137 | CSNK1E | 0.25206828 |
| 138 | CSNK1G3 | 0.23965731 |
| 139 | PRKG2 | 0.23719951 |
| 140 | PAK3 | 0.23559113 |
| 141 | SGK494 | 0.22867281 |
| 142 | SGK223 | 0.22867281 |
| 143 | PDK4 | 0.22040399 |
| 144 | PDK3 | 0.22040399 |
| 145 | TNIK | 0.17834352 |
| 146 | CSNK1A1 | 0.16885420 |
| 147 | PRKCB | 0.16425029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.43948203 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44909207 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.40358983 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17544227 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95729273 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.81750976 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72306737 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.63700639 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57284523 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54311849 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.42989033 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37761369 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30266672 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.24877155 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18036589 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.10659934 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.03302935 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.02501879 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93789255 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93269024 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91573267 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87080247 |
| 23 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85290114 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82707578 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79803967 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.75271037 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73611220 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.69444711 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66697947 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63532346 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62247623 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.53678662 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51791045 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49689571 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45782774 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41192965 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40248575 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.39588736 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39021244 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38888571 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35972483 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28370866 |
| 43 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28012897 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.22894561 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22294027 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18695512 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14508759 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13474808 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.11912991 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.09903718 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.08683488 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02254535 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01393733 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99583111 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99286719 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98432531 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90423410 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90066711 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88469134 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.86097601 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83126954 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.82372523 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76490587 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74724240 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74377407 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73245459 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67047639 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60298015 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59142690 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50323995 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45499694 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.39582777 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39376167 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38746494 |
| 75 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36771008 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36764632 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35844572 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31111207 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30027857 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.28816676 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23468992 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.21492127 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20151989 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17922717 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17458010 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.12982395 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08540711 |
| 88 | Tight junction_Homo sapiens_hsa04530 | 0.02653892 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.01856088 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00696775 |
| 91 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.00014661 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2367826 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2315351 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | -0.2311819 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2209933 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2145952 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2013039 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1949572 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | -0.1870029 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | -0.1774855 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1742197 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1695747 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1482952 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1444012 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1428657 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1245610 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1211894 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1058975 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0831947 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0336954 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0201461 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0191830 |
| 113 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0053907 |
| 114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0031098 |

